Literature DB >> 21624864

Glioblastoma multiforme: enhancing survival and quality of life.

Mary Elizabeth Davis1, Ann Marie Mulligan Stoiber.   

Abstract

A diagnosis of a malignant brain tumor is devastating to patients and their families. The patients' inevitable loss of independence, which can occur suddenly or gradually, is tragic, and the eventual complete dependence can be overwhelming to the family and caregivers. Glioblastoma multiforme (GBM) is the most common type of primary malignant brain tumor in adults and is associated with a disproportionately high mortality rate. The highly malignant tumor grows rapidly and has a tendency to recur through treatment. The brain itself presents a multitude of barriers to treatment, such as tumor location, accessibility for surgery, and the blood-brain barrier's natural protection. Despite access to optimal multimodality treatment, patients diagnosed with GBM have a low survival rate. Patients and families need emotional and practical support throughout the continuum of this devastating disease. Astute neurologic assessment skills and immediate and appropriate interventions are required to maintain the patient's functional status. This article provides an overview of the treatment of GBM and reviews how oncology nurses can intervene to positively improve the quality of life of patients and their families.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21624864     DOI: 10.1188/11.CJON.291-297

Source DB:  PubMed          Journal:  Clin J Oncol Nurs        ISSN: 1092-1095            Impact factor:   1.027


  10 in total

1.  Assessing the quality of life among caregivers of patients with gliomas.

Authors:  Patricia Minaya Flores; Julie Berbis; Olivier Chinot; Pascal Auquier
Journal:  Neurooncol Pract       Date:  2014-10-16

2.  Home visits in brain tumor patient: how nurse and family members cooperate in tumor patient's family self-care.

Authors:  Liwei Lang; Zhiyue Yan; Hailiang Tang
Journal:  Chin J Cancer Res       Date:  2013-12       Impact factor: 5.087

3.  Coping with a newly diagnosed high-grade glioma: patient-caregiver dyad effects on quality of life.

Authors:  K Baumstarck; T Leroy; Z Hamidou; E Tabouret; P Farina; M Barrié; C Campello; G Petrirena; O Chinot; P Auquier
Journal:  J Neurooncol       Date:  2016-06-14       Impact factor: 4.130

4.  Evolution of the Karnosky Performance Status throughout life in glioblastoma patients.

Authors:  Adama Sacko; Miao-Miao Hou; Michael Temgoua; Ali Alkhafaji; Athina Marantidou; Catherine Belin; Emmanuel Mandonnet; Renata Ursu; Jennifer Doridam; Irène Coman; Christine Levy-Piedbois; Antoine F Carpentier
Journal:  J Neurooncol       Date:  2015-02-21       Impact factor: 4.130

Review 5.  Glioblastoma: Overview of Disease and Treatment.

Authors:  Mary Elizabeth Davis
Journal:  Clin J Oncol Nurs       Date:  2016-10-01       Impact factor: 1.027

6.  Epilepsy in Adults with Supratentorial Glioblastoma: Incidence and Influence Factors and Prophylaxis in 184 Patients.

Authors:  Shuli Liang; Junchen Zhang; Shaohui Zhang; Xiangping Fu
Journal:  PLoS One       Date:  2016-07-20       Impact factor: 3.240

7.  A novel tumor-promoting mechanism of IL6 and the therapeutic efficacy of tocilizumab: Hypoxia-induced IL6 is a potent autophagy initiator in glioblastoma via the p-STAT3-MIR155-3p-CREBRF pathway.

Authors:  Hao Xue; Guang Yuan; Xing Guo; Qinglin Liu; Jinsen Zhang; Xiao Gao; Xiaofan Guo; Shugang Xu; Tong Li; Qianqian Shao; Shaofeng Yan; Gang Li
Journal:  Autophagy       Date:  2016-05-10       Impact factor: 16.016

8.  Glioblastoma management: challenges in the elderly population.

Authors:  Niranjan Tachamo; Salik Nazir; Saroj Lohani; Brian Le; Richard Alweis
Journal:  J Community Hosp Intern Med Perspect       Date:  2016-10-26

9.  TRIM28 activates autophagy and promotes cell proliferation in glioblastoma.

Authors:  Yong Peng; Mingming Zhang; Zhongzhong Jiang; Yugang Jiang
Journal:  Onco Targets Ther       Date:  2019-01-03       Impact factor: 4.147

Review 10.  Prognostic and Therapeutic Roles of the Insulin Growth Factor System in Glioblastoma.

Authors:  Elena Tirrò; Michele Massimino; Chiara Romano; Federica Martorana; Maria Stella Pennisi; Stefania Stella; Giuliana Pavone; Sandra Di Gregorio; Adriana Puma; Cristina Tomarchio; Silvia Rita Vitale; Livia Manzella; Paolo Vigneri
Journal:  Front Oncol       Date:  2021-02-02       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.